A detailed history of American National Bank transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, American National Bank holds 1,600 shares of BMY stock, worth $94,192. This represents 0.01% of its overall portfolio holdings.

Number of Shares
1,600
Previous 2,800 42.86%
Holding current value
$94,192
Previous $116,000 29.31%
% of portfolio
0.01%
Previous 0.01%

Shares

24 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 02, 2024

SELL
$39.66 - $51.75 $47,591 - $62,100
-1,200 Reduced 42.86%
1,600 $82,000
Q4 2023

Feb 08, 2024

SELL
$48.48 - $57.85 $139,331 - $166,260
-2,874 Reduced 50.65%
2,800 $143,000
Q3 2023

Oct 10, 2023

BUY
$57.89 - $64.73 $69,468 - $77,676
1,200 Added 26.82%
5,674 $329,000
Q2 2023

Jul 12, 2023

SELL
$63.71 - $70.74 $637 - $707
-10 Reduced 0.22%
4,474 $286,000
Q1 2023

Apr 25, 2023

SELL
$65.71 - $74.53 $18,398 - $20,868
-280 Reduced 5.88%
4,484 $310,000
Q4 2022

Jan 10, 2023

BUY
$68.48 - $81.09 $53,208 - $63,006
777 Added 19.49%
4,764 $343,000
Q3 2022

Oct 05, 2022

BUY
$0.13 - $76.84 $213 - $126,171
1,642 Added 70.02%
3,987 $283,000
Q1 2022

Apr 08, 2022

SELL
$61.48 - $73.72 $84,166 - $100,922
-1,369 Reduced 36.86%
2,345 $171,000
Q4 2021

Feb 09, 2022

SELL
$53.63 - $62.52 $43,493 - $50,703
-811 Reduced 17.92%
3,714 $232,000
Q3 2021

Oct 12, 2021

SELL
$59.17 - $69.31 $2,958 - $3,465
-50 Reduced 1.09%
4,525 $268,000
Q2 2021

Jul 12, 2021

SELL
$61.91 - $67.42 $19,192 - $20,900
-310 Reduced 6.35%
4,575 $306,000
Q1 2021

Apr 09, 2021

SELL
$59.34 - $66.74 $24,329 - $27,363
-410 Reduced 7.74%
4,885 $308,000
Q4 2020

Jan 06, 2021

SELL
$57.74 - $65.43 $317,281 - $359,537
-5,495 Reduced 50.93%
5,295 $328,000
Q3 2020

Oct 06, 2020

BUY
$57.43 - $63.64 $287 - $318
5 Added 0.05%
10,790 $651,000
Q2 2020

Jul 07, 2020

SELL
$54.82 - $64.09 $23,572 - $27,558
-430 Reduced 3.83%
10,785 $634,000
Q1 2020

Apr 06, 2020

BUY
$46.4 - $67.43 $480,240 - $697,900
10,350 Added 1196.53%
11,215 $625,000
Q4 2019

Jan 10, 2020

BUY
$49.21 - $64.19 $42,566 - $55,524
865 New
865 $56,000
Q1 2019

Apr 15, 2019

SELL
$45.12 - $53.8 $16,829 - $20,067
-373 Closed
0 $0
Q4 2018

Jan 11, 2019

SELL
$48.76 - $63.23 $252,479 - $327,404
-5,178 Reduced 93.28%
373 $19,000
Q3 2018

Oct 04, 2018

SELL
$55.19 - $62.25 $10,817 - $12,201
-196 Reduced 3.41%
5,551 $345,000
Q2 2018

Jul 05, 2018

SELL
$50.53 - $62.98 $12,581 - $15,682
-249 Reduced 4.15%
5,747 $318,000
Q1 2018

Apr 10, 2018

SELL
$59.92 - $68.98 $31,338 - $36,076
-523 Reduced 8.02%
5,996 $379,000
Q4 2017

Jan 11, 2018

BUY
$59.94 - $65.35 $55,744 - $60,775
930 Added 16.64%
6,519 $399,000
Q3 2017

Oct 10, 2017

BUY
$55.23 - $63.74 $308,680 - $356,242
5,589
5,589 $356,000

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $125B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track American National Bank Portfolio

Follow American National Bank and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of American National Bank, based on Form 13F filings with the SEC.

News

Stay updated on American National Bank with notifications on news.